Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Positive preclinical results for NuChem's anticancer compounds in lung cancer model

Feb. 12, 1999

TNP-470 inhibits human lung tumor growth and neovascularization

Feb. 11, 1999

Roberts enriches product pipeline with addition of RL-0903

Feb. 11, 1999

Bristol-Myers Squibb and EntreMed modify research agreement

Feb. 11, 1999

Platinum-based chemotherapy for ovarian cancer increases risk of leukemia

Feb. 11, 1999

Combination of TZT-1027 + ara-C provides synergistic antitumor activity

Feb. 10, 1999

ECyd evaluated for mechanism of action, potential clinical activity

Feb. 10, 1999

Nonpeptide GnRH antagonists claimed by Merck & Co.

Feb. 9, 1999

New photoactive agents in development at QLT and U. of British Columbia

Feb. 9, 1999

Hughes Institute enters licensing agreement for anticancer drug development

Feb. 9, 1999

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026